Veracyte | VCYT - 流动负债



金融业
股票价格
USD 44.39
资产
USD 1.49B
现金及等价物
USD 299.52M
销售成本
USD 42.19M
流动资产
USD 574.78M
流动负债
USD 62.74M
债务
USD 39.33M
EBIT
USD 23.96M
EBITDA
USD 43.96M
员工
824
EPS每股收益
USD 0.54
股本和储备
USD 1.39B
销售毛利
USD 108.55M
债务利息支出
USD 2K
利息收入
USD 3.48M
贷款资金
USD 0
市值
USD 3.55B
净收入
USD 25.49M
营业费用
USD 126.36M
营业利润
USD 23.96M
普通股股本
USD 79.79M
PE价格收益
42.77
税前利润
USD 26.52M
销售收入
USD 150.32M
销售和管理费用
USD 55.71M
股票
USD 22.66M
贸易债权人
USD 8.02M
应收帐款人
USD 54.18M


流动负债 更改 日
Agenus USD 231.82M 17.42M 2026-06
Agilent USD 2.29B 20M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Bruker USD 1.2B 150.4M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Illumina USD 1.58B 12M 2026-06
Intrexon USD 23.02M 38K 2024-06
Karyopharm Therapeutics USD 117.3M 25.24M 2026-03
Laboratory Of America USD 2.12B 516.4M 2026-06
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
Rigel Pharmaceuticals USD 94.4M 7.76M 2025-09
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Siemens EUR 45.11B 4.4B 2026-06
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Veracyte USD 62.74M 6.62M 2026-06
Waters USD 2.27B 1.03B 2026-03